The natural product magnolol as a lead structure for the development of potent cannabinoid receptor agonists.
Magnolol (4-allyl-2-(5-allyl-2-hydroxyphenyl)phenol), the main bioactive constituent of the medicinal plant Magnolia officinalis, and its main metabolite tetrahydromagnolol were recently found to activate cannabinoid (CB) receptors. We now investigated the structure-activity relationships of (tetrah...
Guardado en:
Autores principales: | Alexander Fuchs, Viktor Rempel, Christa E Müller |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c1793116671740df9aadfcc075109511 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Assessment of select synthetic cannabinoid receptor agonist bias and selectivity between the type 1 and type 2 cannabinoid receptor
por: Ayat Zagzoog, et al.
Publicado: (2021) -
Honokiol and Magnolol: Insights into Their Antidermatophytic Effects
por: Adriana Trifan, et al.
Publicado: (2021) -
Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent
por: Hanlon KE, et al.
Publicado: (2016) -
1,2,3-Triazole derivatives as highly selective cannabinoid receptor type 2 (CB2) agonists
por: Amer H. Tarawneh, et al.
Publicado: (2022) -
A cell-free platform for the prenylation of natural products and application to cannabinoid production
por: Meaghan A. Valliere, et al.
Publicado: (2019)